Evidence map›Paper›PMID 26489655›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

The adherens junctions control susceptibility to Staphylococcus aureus α-toxin.

Lauren M Popov, Caleb D Marceau, Philipp M Starkl, Jennifer H Lumb, Jimit Shah, Diego Guerrera, Rachel L Cooper, Christina Merakou, Donna M Bouley, Wenxiang Meng and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. The Pathogenicity Mechanisms ofInternational journal of molecular sciences · 2025
    Review
  4. Strategies for Survival ofInternational journal of molecular sciences · 2025
    Review
  5. Review
  6. NArchives of microbiology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecular Characteristics and Pathogenicity ofInternational journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 3 countries.

Lauren M PopovDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305;
Caleb D MarceauDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305;
Philipp M StarklDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305;
Jennifer H LumbDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305;
Jimit ShahDepartment of Cell Biology, University of Geneva, 1205 Geneva, Switzerland;
Diego GuerreraDepartment of Cell Biology, University of Geneva, 1205 Geneva, Switzerland;ORCID http://orcid.org/0000-0002-5323-4447
Rachel L CooperDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305;
Christina MerakouGlaxo Smith Kline Vaccines, Società a Responsabilità Limitata, 53100 Siena, Italy;
Donna M BouleyDepartment of Comparative Medicine, Stanford University School of Medicine, Stanford, CA 94305;
Wenxiang MengInstitute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101 Beijing, China; RIKEN Center for Developmental Biology, Kobe 650-0047, Japan;
Hiroshi KiyonariAnimal Resource Development Unit and Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe 650-0047, Japan;
Masatoshi TakeichiRIKEN Center for Developmental Biology, Kobe 650-0047, Japan;
Stephen J GalliDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305;
Fabio BagnoliGlaxo Smith Kline Vaccines, Società a Responsabilità Limitata, 53100 Siena, Italy;
Sandra CitiDepartment of Cell Biology, University of Geneva, 1205 Geneva, Switzerland;
Jan E CaretteDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305; amieva@stanford.edu carette@stanford.edu.
Manuel R AmievaDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305 amieva@stanford.edu carette@stanford.edu.
Stanford University · USUniversity of Geneva · CHChinese Academy of Sciences · CN

Funding

MOLECULAR BASIS OF HOST-PARASITE INTERACTIONT32AI007328 · NIAID · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 1987 to 2026
$11.9M
Genetic approaches to discover host factors critical to dengue virus infectionDP2AI104557 · NIAID · STANFORD UNIVERSITY · PI CARETTE, JAN E · 2012 to 2012
$2.3M
Role of novel adherens junction proteins in susceptibility to S. aureus alpha-toxinR21AI117255 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R · 2016 to 2017
$442k
Research Career Development: Investigation of novel Staphylococcus aureus alpha-toxin targets at the cellular adherens junctionsF31AI118212 · NIAID · STANFORD UNIVERSITY · PI POPOV, LAUREN · 2015 to 2016
$60k
NIAID NIH HHS DP2 AI104557NIAID NIH HHS F31 AI118212NIAID NIH HHS F31AI118212NIAID NIH HHS R21 AI117255NIAID NIH HHS T32 AI007328
6 · The paper itself

Abstract

Staphylococcus aureus is both a transient skin colonizer and a formidable human pathogen, ranking among the leading causes of skin and soft tissue infections as well as severe pneumonia. The secreted bacterial α-toxin is essential for S. aureus virulence in these epithelial diseases. To discover host cellular factors required for α-toxin cytotoxicity, we conducted a genetic screen using mutagenized haploid human cells. Our screen identified a cytoplasmic member of the adherens junctions, plekstrin-homology domain containing protein 7 (PLEKHA7), as the second most significantly enriched gene after the known α-toxin receptor, a disintegrin and metalloprotease 10 (ADAM10). Here we report a new, unexpected role for PLEKHA7 and several components of cellular adherens junctions in controlling susceptibility to S. aureus α-toxin. We find that despite being injured by α-toxin pore formation, PLEKHA7 knockout cells recover after intoxication. By infecting PLEKHA7(-/-) mice with methicillin-resistant S. aureus USA300 LAC strain, we demonstrate that this junctional protein controls disease severity in both skin infection and lethal S. aureus pneumonia. Our results suggest that adherens junctions actively control cellular responses to a potent pore-forming bacterial toxin and identify PLEKHA7 as a potential nonessential host target to reduce S. aureus virulence during epithelial infections.

Indexed as

ADAM10 ProteinADAM ProteinsAdherens JunctionsAmyloid Precursor Protein SecretasesAnimalsBacterial ToxinsCarrier ProteinsCell LineHemolysin ProteinsHumansMembrane ProteinsMethicillin-Resistant Staphylococcus aureusMiceMice, KnockoutStaphylococcal InfectionsVasculitisADAM10 ProteinADAM10 protein, humanAdam10 protein, mouseADAM ProteinsAmyloid Precursor Protein SecretasesBacterial ToxinsCarrier ProteinsHemolysin ProteinsMembrane ProteinsPLEKHA7 protein, humanPLEKHA7 protein, mousestaphylococcal alpha-toxinadherens junctionsMRSAPLEKHA7Staphylococcus aureusα-toxin

Identifiers

PMID26489655
PMCPMC4655540
OpenAlexW2157075798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.